Magnetic particle imaging (MPI) is a new imaging modality with the potential for high‐
resolution imaging while retaining the noninvasive nature of other current modalities such as …

Background Islet transplantation (Tx) represents the most promising therapy to restore
normoglycemia in type 1 diabetes (T1D) patients to date. As significant islet loss has been …

The ability to detect and target β cells in vivo can substantially refine how diabetes is studied
and treated. However, the lack of specific probes still hampers a precise characterization of …

Purpose Current approaches to quantification of magnetic particle imaging (MPI) for cell-
based therapy are thwarted by the lack of reliable, standardized methods of segmenting the …

The incidence of accidental and intentional acid skin burns is rising. Current treatment
strategies are mostly inadequate, leaving victims disfigured and without treatment options …

Clinical outcomes for total-pancreatectomy followed by intraportal islet autotransplantation
(TP-IAT) to treat chronic pancreatitis (CP) are suboptimal due to pancreas inflammation …

There are presently no reliable ways to quantify human pancreatic beta cell mass (BCM) in
vivo, which prevents an accurate understanding of the progressive beta cell loss in diabetes …

Intrahepatic transplantation of islets of Langerhans (ITx) is a treatment option for individuals
with complicated type 1 diabetes and profoundly unstable glycemic control, but its …

The long-term success of pancreatic islet transplantation (Tx) as a cure for type 1 diabetes
remains limited. Islet loss after Tx related to apoptosis, inflammation, and other factors …

Transplanting islets of Langerhans consists of implantation in the recipient's hepatic portal
system of endocrine pancreatic tissue, with a variable degree of purification. The field of islet …